Search

Zoetis Inc

Abierto

SectorSanidad

74.76 2.92

Resumen

Variación precio

24h

Actual

Mínimo

71.41

Máximo

73.29

Métricas clave

By Trading Economics

Ingresos

-2M

601M

Ventas

-125M

2.3B

P/B

Media del Sector

12.639

68.51

BPA

1.53

Rentabilidad por dividendo

2.63

Margen de beneficios

26.569

Empleados

14,500

EBITDA

-8M

939M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+24.9% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

2.63%

2.29%

Próximas Ganancias

3 nov 2026

Fecha Próximo Dividendo

1 sept 2026

Próxima Fecha de Ex Dividendo

30 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-15B

32B

Apertura anterior

71.84

Cierre anterior

74.76

Noticias sobre sentimiento de mercado

By Acuity

58%

42%

259 / 340 Clasificación en Healthcare

Zoetis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 ago 2026, 00:01 UTC

Zoetis Inc. shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics influenced by recent economic data.

7 ago 2026, 23:01 UTC

Zoetis shares advanced in after-market trading, showing notable activity despite being below the 20-day moving average and near the lower end of its one-month range.

6 ago 2026, 23:26 UTC

News

Zoetis Inc shows a modest advance in after-market trading, now valued at approximately $31.19 billion, ranking as the 298th largest firm by market capitalization.

5 ago 2026, 23:41 UTC

Zoetis Inc. shares declined in after-market trading, remaining below their 20-day moving average despite earlier gains. Asian markets, including the Nikkei 225, performed positively.

4 ago 2026, 19:26 UTC

Zoetis Inc shares are lower today amid unusual volatility, reaching a session low earlier. No specific news was identified to explain the movement.

3 ago 2026, 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1 ago 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31 jul 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30 jul 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29 jul 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28 jul 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27 jul 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25 jul 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24 jul 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23 jul 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22 jul 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21 jul 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20 jul 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Comparación entre iguales

Cambio de precio

Zoetis Inc previsión

Precio Objetivo

By TipRanks

24.9% repunte

Estimación a 12 Meses

Media 90.75 USD  24.9%

Máximo 112 USD

Mínimo 80 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zoetis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

4

Comprar

7

Mantener

0

Vender

Sentimiento

By Acuity

259 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.